Human medicines European public assessment report (EPAR): Adtralza, tralokinumab, Date of authorisation: 17/06/2021, Revision: 8, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 27 October 2025 - 14:24

Human medicines European public assessment report (EPAR): Adtralza, tralokinumab, Date of authorisation: 17/06/2021, Revision: 8, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/adtralza

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters